Oct 1, 2026, 09:16 by

Biopharma PEG expands its portfolio of functionalized PEG linkers for bioconjugation and pharmaceutical research, including azide, alkyne, DBCO, and BCN PEG derivatives, alongside monodispersed, polydispersed, and custom PEG solutions.

Oct 1, 2026, 09:16 by

Hunan Huateng Pharmaceutical Co., Ltd. will exhibit at CPHI Milan 2026, Booth 3H94, showcasing high-purity PEG products, pharmaceutical intermediates, APIs, and CDMO capabilities. The company supports pharmaceutical and biopharmaceutical projects from research and process development through manufacturing.

Oct 1, 2026, 09:16 by

Oct 1, 2026, 09:15 by

Researchers in the University’s Integrative Physiology Lab will evaluate Openwater’s wearable platform for studying muscle blood-flow dynamics and vascular responses to nervous system activity, with potential future applications in noninvasive neural communication

Oct 1, 2026, 09:15 by

Oct 1, 2026, 09:15 by

Oct 1, 2026, 01:00 by User Not Found

Clinical Research News | Funding news from around the biotech space including investments in Phase 2 sepsis, leukemia peptide immunotherapy, colon cancer, Phase 1 obesity, atherosclerosis, more.

Sep 30, 2026, 01:01 by User Not Found

Clinical Research News | Alliance trial finds fractionated radiosurgery reduces recurrence after brain metastasis surgery; FDA clears CU Anschutz CAR T-cell trial for colorectal cancer; Syneos Health and Tufts CSDD study links trial performance to operating model design; and more.

Sep 24, 2026, 17:26 by

Sep 24, 2026, 17:26 by

• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples

Sep 24, 2026, 17:26 by

Veeva Systems today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol.

Sep 24, 2026, 17:26 by

Sep 24, 2026, 17:26 by

New identity unites three site organizations under one banner as company expands beyond its vaccine-trial roots into multi-therapeutic clinical research site network

Sep 24, 2026, 17:26 by

Published in the special Focus Issue on Innovations in Heart Transplantation in the Journal of Cardiac Failure, the GUARDIAN-Heart analysis across 18 U.S. transplant centers identifies $14,982 in net per-patient cost savings across multiple measured categories spanning post-transplant support, hospital care, organ preservation, and readmissions.

Sep 24, 2026, 01:01 by User Not Found

Clinical Research News | Genialis and Inventia Life Science yesterday announced a collaboration to improve how new treatments for pancreatic cancer are tested and the patients most likely to benefit are enrolled in trials. The companies will combine Genialis' AI-powered patient insights with Inventia's RASTRUM 3D cell model platform to build human-relevant models of pancreatic ductal adenocarcinoma (PDAC) that correspond to the tumor biology of identifiable patient populations.

Sep 22, 2026, 01:01 by User Not Found

Clinical Research News | Last week, Condor launched a new clinical finance agent that gives R&D teams the "why" behind variances, runs full what-if scenario planning, and then builds the resulting model directly in Condor. It's part of a team of agents built on Condor's clinical and financial ontology and knowledge graph.

Sep 18, 2026, 13:06 by

Sep 18, 2026, 13:06 by

Upperton, a UK-based contract development and manufacturing organisation (CDMO), today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved a variation to its existing Manufacturing and Importation Authorisation for Investigational Medicinal Products (MIA(IMP)) licence, extending its scope to include the company’s new Annex 1-aligned sterile manufacturing facility at Trent Gateway, Nottingham.

Sep 18, 2026, 01:01 by User Not Found

Clinical Research News | This week Mayo Clinic announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific. Precure will create one of the world’s leading biomedical datasets by integrating proteomic, genomic, and longitudinal clinical data to help researchers identify early biological signals of disease and provide a foundation for new discoveries in disease biology, diagnostics and therapeutics.

Sep 16, 2026, 15:20 by

New name, visual identity and website position Ann Arbor preclinical CRO for its next phase of scientific growth